http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0880967-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34c531b0dce54fb192c75fd1f4f8d473
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
filingDate 1998-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edf53a939baa5a395df46514b901b970
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2242fa3f18f9ffaaa5c1093962b997d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08e304704f1e892a0b4d6a17ea9224b1
publicationDate 1999-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0880967-A3
titleOfInvention Nephroprotective drug
abstract There will be the use of subantihypertensive dosesnof moxonidine and its physiologically acceptable acid addition saltsnfor the manufacture of pharmaceutical preparationsnfor blood pressure-independent treatment and / ornProphylaxis of renal failure described.
priorityDate 1997-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9626728-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134396547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440995

Total number of triples: 25.